Bio-Techne's Commitment to Neuroscience Research
Bio-Techne Corporation (NASDAQ: TECH) is preparing for an exciting presentation at the Society for Neuroscience's annual meeting, Neuroscience 2024. Scheduled for October 5-9 in Chicago, this prestigious event will feature Bio-Techne as they share advancements that are setting new standards in neuroscience research.
Innovative Solutions on Display
At booth #1165, attendees can check out Bio-Techne's extensive range of life science reagents and analytical instruments. This impressive lineup includes state-of-the-art immunoassays and multiomics solutions, all aimed at simplifying the research process. These tools are designed to boost biomarker discovery, improve neural cell cultures, and innovate drug screening methods.
Highlighting Key Presentations and Technologies
Throughout the event, Bio-Techne will host a nanosymposium on the critical topic of senescence in the aging brain. This session will feature the RNAscope™ Multiomic LS assay, which supports high-throughput spatial analysis for complicated biological systems. Moreover, a poster presentation will emphasize the company's dedication to antibody validation using the hyperplex spatial biology platform from Lunaphore, a move that significantly enhances research accuracy.
Collaboration Spotlight with FUJIFILM Cellular Dynamics
In partnership with FUJIFILM Cellular Dynamics, Bio-Techne will present a Product Theater showcasing intracellular signaling in Alzheimer's disease, with a special emphasis on Simple Western™ automated western technology. This cutting-edge technology enables precise protein size characterization directly from complex samples like tissue or cell lysates, marking an important breakthrough in neurobiological research tools.
Scientific Presentations at the Conference
Bio-Techne's participation in Neuroscience 2024 includes several key presentations, such as:
- Simple Western™ Capillary Immunoassays: This innovative approach to detailing intracellular signaling in Alzheimer's disease is scheduled for October 7 at 2:30 pm.
- Investigating Hallmarks of Senescence: A presentation on October 9 will cover a novel RNA-Protein Multiomic Co-Detection Assay.
- Automated Assay for Precise pTau217 Quantification: Set for October 6, this session will showcase techniques that improve sensitivity in detecting disease markers.
- Bridging Synaptic Research: Focusing on the interactions between neurexin and neuroligin, this presentation on October 6 will utilize multiomic RNAscope technology for in-depth studies.
- Spatial Multiomic Assay Analysis: Scheduled for October 8, it will delve into interneuron heterogeneity in the brain.
Additionally, a collaborative presentation will focus on characterizing iPSC-derived human microglial activation, showcasing the integration of advanced technologies in neuroinflammation research.
About Bio-Techne Corporation
Bio-Techne Corporation (NASDAQ: TECH) is a frontrunner in life sciences, offering innovative tools and reagents critical for research and clinical diagnostics. With an extensive portfolio of hundreds of thousands of products, Bio-Techne supports scientific exploration of biological mechanisms and disease progression. Their work propels drug discovery and aids in the development of precise diagnostic tests. In the last fiscal year, Bio-Techne reported around $1.2 billion in net sales and employs about 3,100 professionals worldwide.
Frequently Asked Questions
What will Bio-Techne present at Neuroscience 2024?
Bio-Techne will showcase a range of innovative life science solutions, focusing on tools for neurological research and advancements in biomarker discovery.
Where will the event take place?
The Neuroscience 2024 annual meeting will happen in Chicago from October 5-9, highlighting the latest findings in the field of neuroscience.
What technologies will be highlighted?
Attendees can expect to see demonstrations of high-quality life science reagents, immunoassays, and techniques for spatial biology analysis.
Who will represent Bio-Techne at the conference?
Key figures, including Kim Kelderman, Bio-Techne's President and CEO, along with leading scientists from FUJIFILM and Cell Signaling Technology, will be presenting.
How can I learn more about Bio-Techne's offerings?
To dive deeper into Bio-Techne's innovative products and solutions for neuroscience and more, visit their official website.
